Astaxanthin improves nonalcoholic fatty liver disease in Werner syndrome with diabetes mellitus

Journal of the American Geriatrics Society

Volumn 63, Issue 6, 2015, Pages 1271-1273

  Takemoto, Minoru ^a,b   Yamaga, Masaya ^a,b   Furuichi, Yasuhiro ^c   Yokote, Koutaro ^a,b  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c GeneCare Research Institute Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ASTAXANTHIN; ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; CHOLINESTERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYALURONIC ACID; IMMUNOREACTIVE INSULIN; LOW DENSITY LIPOPROTEIN; TELMISARTAN; TRIACYLGLYCEROL; XANTHOPHYLL;

ACHILLES TENDON; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY HEIGHT; BODY MASS; BODY WEIGHT; CASE REPORT; CATARACT; CHOLESTEROL BLOOD LEVEL; CHOLINESTERASE BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LETTER; LIVER FIBROSIS; MARRIAGE; MEDICAL EXAMINATION; MENINGIOMA; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; SKIN ULCER; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL; WERNER SYNDROME; COMPLICATION; NON-ALCOHOLIC FATTY LIVER DISEASE;

DIABETES COMPLICATIONS; FEMALE; HUMANS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; WERNER SYNDROME; XANTHOPHYLLS;

EID: 84931294054     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13505     Document Type: Letter

References (10)

1. Okabe E, Takemoto M, Onishi S, et al., Incidence and characteristics of metabolic disorders and vascular complications in individuals with Werner syndrome in Japan. J Am Geriatr Soc 2012; 60: 997-998.
2. Takemoto M, Mori S, Kuzuya M, et al., Diagnostic criteria for Werner syndrome based on Japanese nationwide epidemiological survey. Geriatr Gerontol Int 2013; 13: 475-481.
3. Mori S, Morisaki N, Murano S, et al., Fatty liver as a complication of patients with Werner's syndrome. Nihon Ronen Igakkai Zasshi 1988; 25: 626-631.
4. Hashizume H, Sato K, Takagi H, et al., Werner syndrome as a possible cause of non-alcoholic steatohepatitis. J Clin Pathol 2009; 62: 1043-1045.
5. Mori S, Murano S, Yokote K, et al., Enhanced intra-abdominal visceral fat accumulation in patients with Werner's syndrome. Int J Obes Relat Metab Disord 2001; 25: 292-295.
6. Yokote K, Honjo S, Kobayashi K, et al., Metabolic improvement and abdominal fat redistribution in Werner syndrome by pioglitazone. J Am Geriatr Soc 2004; 52: 1582-1583.
7. Goto M, Iwaki-Egawa S, Watanabe Y,. Ageing in Werner syndrome. Biosci Trends 2012; 6: 33-37.
8. Bhuvaneswari S, Yogalakshmi B, Sreeja S, et al., Astaxanthin reduces hepatic endoplasmic reticulum stress and nuclear factor-kappaB-mediated inflammation in high fructose and high fat diet-fed mice. Cell Stress Chaperones 2014; 19: 183-191.
9. Onishi S, Takemoto M, Ishikawa T, et al., Japanese diabetic patients with Werner syndrome exhibit high incidence of cancer. Acta Diabetol 2012; 49 (Suppl 1): S259-S260.
10. Okano H, Isono Y, Tanaka H, et al., Primary liver tumor associated with Werner syndrome (adult progeria). Hepatol Res 2011; 41: 1260-1265.